Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures

European Journal of Nutrition

Volumn 47, Issue 5, 2008, Pages 273-279

  Ohtomo, Takuya ^a,b   Uehara, Mariko ^c   Peñalvo, José Luis ^d   Adlercreutz, Herman ^d   Katsumata, Shin Ichi ^c   Suzuki, Kazuharu ^c   Takeda, Ken ^b   Masuyama, Ritsuko ^e   Ishimi, Yoshiko ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bone mineral density; Equol; Microflora; O desmethylangolensin; Osteoclast

Indexed keywords

CALCITRIOL; DAIDZEIN; EQUOL; ESTRADIOL; ISOFLAVONE DERIVATIVE; LIPID; O DESMETHYLANGOLENSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE DENSITY; BONE MARROW CELL; BONE MARROW CULTURE; CELL CULTURE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; FEMUR; IN VITRO STUDY; IN VIVO STUDY; LIPID BLOOD LEVEL; LIPID METABOLISM; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OVARIECTOMY; SHAM PROCEDURE; UTERUS ATROPHY; UTERUS DISEASE; UTERUS WEIGHT;

ANIMALS; BONE DENSITY; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS, NON-STEROIDAL; FEMALE; ISOFLAVONES; LIPID METABOLISM; MICE; MICE, INBRED STRAINS; OSTEOCLASTS; OSTEOPOROSIS; OVARIECTOMY; RANDOM ALLOCATION;

GLYCINE MAX; MUS;

EID: 48749084087     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-008-0723-x     Document Type: Article

References (29)

1. CH Adlercreutz BR Goldin SL Gorbach KA Höckerstedt S Watanabe EK Hämäläinen MH Markkanen TH Makela KT Wähälä T Adlercreutz 1995 Soybean phytoestrogen intake and cancer risk J Nutr 125 757S 770S
2. C Atkinson CL Frankenfeld JW Lampe 2005 Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health Exp Biol Med 230 155 170
3. Bannwart C, Adlercreutz H, Fotsis T, Wähälä K, Hase T, Brunow G (1984) Identification of O-desmethylangolensin, a metabolite of daidzein, and of matairesinol, one likely plant precursor of the animal lignan enterolactone, in human urine. Finn Chem Lett 11:120-125
4. V Beral D Bull G Reeves 2005 Endometrial cancer and hormone-replacement therapy in the Million Women Study Lancet 365 1543 1551
5. E Brouwers R L'homme N Al-Maharik O Lapcík R Hampl K Wähälä H Mikola H Adlercreutz 2003 Time-resolved fluoroimmunoassay for equol in plasma and urine J Steroid Biochem Mol Biol 84 577 588
6. CL Frankenfeld C Atkinson WK Thomas A Gonzalez T Jokela K Wähälä SM Schwartz SS Li JW Lampe 2005 High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart Br J Nutr 94 873 876
7. C Frankenfeld C Atkinson WK Thomas EL Goode A Gonzalez T Jokela K Wähälä SM Schwartz SS Li JW Lampe 2004 Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes Exp Biol Med (Maywood) 229 902 913
8. CL Frankenfeld A McTiernan WK Thomas K LaCroix L McVarish VL Holt SM Schwartz JW Lampe 2005 Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes Maturitas 53 315 324
9. M Fujioka M Uehara J Wu H Adlercreutz K Suzuki K Kanazawa K Takeda K Yamada Y Ishimi 2004 Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice J Nutr 134 2623 2627
10. WL Hall K Vafeiadou J Hallund S Bügel C Koebnick M Reimann M Ferrari F Branca D Talbot T Dadd M Nilsson K Dahlman-Wright JA Gustafsson AM Minihane CM Williams 2005 Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 82 1260 1268
11. HG Hur RD Beger TM Heinze JO Lay Jr JP Freeman J Dore F Rafii 2002 Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein Arch Microbiol 178 8 12
12. AM Inzerillo M Zaidi 2002 Osteoporosis: trends and intervention Mt Sinai J Med 69 220 231
13. GE Joannou GE Kelly AY Reeder M Waring C Nelson 1995 A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids J Steroid Biochem Mol Biol 54 167 184
14. J Kinjo R Tsuchihashi K Morito T Hirose T Aomori T Nagao H Okabe T Nohara Y Masamune 2004 Interactions of phytoestrogens with estrogen receptors alpha and beta (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine Biol Pharm Bull 27 185 188
15. R L'homme E Brouwers N Al-Maharik O Lapcík R Hampl H Mikola K Wähälä H Adlercreutz 2002 Time-resolved fluoroimmunoassay of plasma and urine O-desmethylangolensin J Steroid Biochem Mol Biol 81 353 361
16. L Lehmann HI Esch J Wagner L Rohnstock M Metzler 2005 Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of daidzein in cultured human Ishikawa cells Toxicol Lett 158 72 86
17. MJ Messina 2002 Soy foods and soy isoflavones and menopausal health Nutr Clin Care 5 272 282
18. VW Persky ME Turyk L Wang S Freels RJ Chatterton S Barnes JW Erdman Jr DW Spekovic HL Bradlow SM Potter 2002 Effect of soy protein on endogenous hormones in postmenopausal women Am J Clin Nutr 75 145 153
19. KR Price GR Fenwick 1985 Naturally occurring oestrogens in foods-a review Food Addit Contam 2 73 106
20. PG Reeves FH Nielsen GC Fahey Jr 1993 AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet J Nutr 123 1939 1951
21. IR Rowland H Wiseman TA Sanders H Adlercreutz EA Bowey 2000 Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora Nutr Cancer 36 27 32
22. KD Setchell NM Brown E Lydeking-Olsen 2002 The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones J Nutr 132 3577 3584
23. JH Sung SJ Lee KH Park TW Moon 2004 Isoflavones inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase in vitro Biosci Biotechnol Biochem 68 428 432
24. N Takahashi T Akatsu N Udagawa T Sasaki A Yamaguchi JM Moseley TJ Martin T Suda 1998 Osteoblastic cells are involved in osteoclast formation Endocrinology 123 2600 2602
25. J Wu J Oka J Ezaki T Ohtomo T Ueno S Uchiyama T Toda M Uehara Y Ishimi 2007 Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial Menopause 14 624 629
26. J Wu J Oka M Higuchi I Tabata T Toda M Fujioka N Fuku T Teramoto T Okuhira T Ueno S Uchiyama K Urata K Yamada Y Ishimi 2006 Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial Metabolism 55 423 433
27. J Wu X Wang H Chiba M Higuchi T Nakatani O Ezaki H Cui K Yamada Y Ishimi 2004 Combined intervention of soy isoflavones and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice Metabolism 53 942 948
28. S Yamamoto T Sobue M Kobayashi S Sasaki S Tsugane 2003 Soy, isoflavones, and breast cancer risk in Japan J Natl Cancer Inst 95 906 913
29. XG Zhuo MK Melby S Watanabe 2004 Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans J Nutr 134 2395 2400